nav-left cat-right

Boehringer is winning on social media

Biopharma has encountered more critics than cheerleaders as it has cautiously edged into social media, but Boehringer Ingelheim has recently won a high-profile supporter–Twitter ($TWTR). In a case study, the social network praised Boehringer’s use of its platform.

PMLiVE spotted the case study on Twitter’s business-focused website. On the site, Twitter describes the social media tactics that have helped companies involved in publishing, entertainment and other consumer-focused industries, but there are noticeably fewer healthcare success stories. Boehringer is the first biopharma company to be picked out by Twitter. In its Boehringer case study, Twitter focuses in on the German biopharma’s chronic obstructive pulmonary disease (COPD) tweet chats.